Bortezomib-based combination regimens in myeloma: More is not necessarily better

Research output: Contribution to journalComment/debate

Fingerprint Dive into the research topics of 'Bortezomib-based combination regimens in myeloma: More is not necessarily better'. Together they form a unique fingerprint.